Literature DB >> 7075142

Results of radical radiotherapy of squamous cell carcinoma of the oesophagus.

G A Newaishy, G A Read, W Duncan, G R Kerr.   

Abstract

A retrospective study was undertaken of 444 patients who were referred with squamous cell carcinoma of the oesophagus during the period January 1956 to December 1974 and who were treated by radical radiotherapy. The overall crude survival rate at 5 years was 9.0% which is similar to the results of most series reported from other centres and compares favourably with the results of radical surgery. The crude 5 year survival rate was 5.7% for males and 11.6% for females, a significant difference (P less than 0.05). Survival is analysed in terms of sex, site, size and histological grade. Patients (males and females) with the best 5-year survival rates had tumours no more than 5.0 cm in length (11.9%) or confined to the cervical oesophagus (18.9%). Histological grade appeared to have no influence on prognosis. The principal morbidity associated with radical radiotherapy is fibrous stricture formation. This occurred in 43.7% of the patients but was usually effectively managed by bouginage.

Entities:  

Mesh:

Year:  1982        PMID: 7075142     DOI: 10.1016/s0009-9260(82)80288-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  13 in total

1.  Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer.

Authors:  Yusuke Yoda; Tomonori Yano; Kazuhiro Kaneko; Shinya Tsuruta; Yasuhiro Oono; Takashi Kojima; Keiko Minashi; Hiroaki Ikematsu; Atsushi Ohtsu
Journal:  Surg Endosc       Date:  2012-04-28       Impact factor: 4.584

Review 2.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 3.  Squamous cell carcinoma of the oesophagus: 10 years on.

Authors:  G A Khoury
Journal:  Ann R Coll Surg Engl       Date:  1991-01       Impact factor: 1.891

4.  Palliation of malignant dysphagia: surgery, radiotherapy, laser, intubation alone or in combination?

Authors:  S G Bown
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

5.  Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.

Authors:  Kohei Shitara; Kei Muro
Journal:  Gastrointest Cancer Res       Date:  2009-03

Review 6.  Useful strategies to prevent severe stricture after endoscopic submucosal dissection for superficial esophageal neoplasm.

Authors:  Kaname Uno; Katsunori Iijima; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

7.  Radiation sensitivities of 31 human oesophageal squamous cell carcinoma cell lines.

Authors:  Sadayuki Ban; Yuichi Michikawa; Ken-ichi Ishikawa; Masashi Sagara; Koji Watanabe; Yutaka Shimada; Johji Inazawa; Takashi Imai
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

8.  Cancer of the esophagus. The Cleveland Clinic experience.

Authors:  S Galandiuk; R E Hermann; D M Cosgrove; J J Gassman
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

9.  Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?

Authors:  Reubendra Jeganathan; James McGuigan; Frederick Campbell; Thomas Lynch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-16       Impact factor: 9.236

Review 10.  Advanced esophageal carcinoma.

Authors:  T E Lerut; P de Leyn; W Coosemans; D Van Raemdonck; P Cuypers; B Van Cleynenbreughel
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.